Develops oral T-cell immunotherapies for cancer and other diseases.
Jun 2026Revenue $1.81M/yrExpenses $18.7M/yr
No trendCash runway ≈ 2 months from Jun 2026
Figures by year
When will OSR Health be profitable?
Its figures don’t show a steady enough trend to project a date. In the 12 months to Jun 2026, revenue was $1.81M and expenses $18.7M.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Dec 2025 | $2.91M | $21.2M | −$18.3M |
| Dec 2024 | $3.53M | $15.2M | −$11.7M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.